Kunming Longjin Pharmaceutical Co., Ltd.

Shenzhen Stock Exchange 002750.SZ

Kunming Longjin Pharmaceutical Co., Ltd. Shares (Diluted, Weighted) for the year ending December 31, 2023: 400,500,000

Kunming Longjin Pharmaceutical Co., Ltd. Shares (Diluted, Weighted) is 400,500,000 for the year ending December 31, 2023, a 0.00% change year over year. Shares (diluted, weighted) are the number of outstanding shares used to calculate earnings per share (EPS) assuming the conversion of all potentially dilutive securities.

Kunming Longjin Pharmaceutical Co., Ltd. Shares (Diluted, Weighted) for the year ending December 31, 2022 was 400,500,000, a 0.00% change year over year.
Kunming Longjin Pharmaceutical Co., Ltd. Shares (Diluted, Weighted) for the year ending December 31, 2021 was 400,500,000, a 0.00% change year over year.
Kunming Longjin Pharmaceutical Co., Ltd. Shares (Diluted, Weighted) for the year ending December 31, 2020 was 400,500,000, a 0.00% change year over year.
Kunming Longjin Pharmaceutical Co., Ltd. Shares (Diluted, Weighted) for the year ending December 31, 2019 was 400,500,000, a -0.09% change year over year.

Key data

Date	Shares (Diluted, Weighted)	Revenue	Cost of Revenue	Gross Profit

Shenzhen Stock Exchange: 002750.SZ

Kunming Longjin Pharmaceutical Co., Ltd.

CEO	Mr. Ya He Li
IPO Date	March 24, 2015
Location	China
Headquarters	NO.789, Lanmao Road
Employees	285
Sector	Health Care
Industries Pharmaceuticals Paper & Forest Products

Description

Kunmig Longjin Pharmaceutical Co., Ltd. develops, produces, and sells natural botanicals and chemical freeze-dried powder injections in China. The company offers Chinese, biochemical, chemical, cardio-cerebral vascular, and digestive system medicines; immune system and first aid medications; and vitamins, minerals, and enteral and parenteral nutrition products. It also engages in the industrial hemp plantation business. The company was founded in 1996 and is headquartered in Kunming, China.

Key trends

Past 5 years